Target intelligence / Profile preview

Microbial and tissue components

Molecular classification
Other
01

Overview

Microbial and tissue components refer to a broad category of biological molecules that serve as triggers for the innate immune system. This group includes Pathogen-Associated Molecular Patterns (PAMPs), such as lipopolysaccharides and viral nucleic acids, as well as Damage-Associated Molecular Patterns (DAMPs), such as HMGB1 and heat shock proteins released during cellular stress [Janeway & Medzhitov, 2002; Kumar, 2020]. These components are recognized by Pattern Recognition Receptors (PRRs), including Toll-like receptors (TLRs), which subsequently activate inflammatory pathways and shape the adaptive immune response [Akira et al., 2006]. In clinical pharmacology, these components are utilized as active ingredients in vaccines and immunomodulators, such as the BCG vaccine for bladder cancer or bacterial lysates for respiratory health, to enhance immune surveillance [StatPearls, 2023]. Conversely, certain drugs like Polymyxin B are designed to bind and neutralize specific microbial components like endotoxins to treat severe conditions such as sepsis [PubChem]. Because this term describes a heterogeneous class of ligands rather than a specific molecular entity, it is not classified as a canonical therapeutic target.

Other names
Pathogen-associated molecular patternsDamage-associated molecular patternsPAMPsDAMPsMicrobial lysatesAlarminsMAMPs
02

Mechanism of action

These components function as ligands for Pattern Recognition Receptors (PRRs), such as Toll-like receptors (TLRs) and NOD-like receptors (NLRs), to initiate innate immune signaling or are neutralized by drugs to prevent excessive inflammatory responses [Akira et al., 2006; Kumar, 2020].

03

Biological functions

Immune responseInflammationPattern recognitionSignal transduction
04

Disease associations

InfectionCancerSepsisInflammation
05

Safety considerations

Cytokine release syndromeSystemic inflammatory response syndrome (SIRS)AutoimmunityAnaphylaxis
06

Interacting drugs

Polymyxin B

4 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)ProcalcitoninInterleukin-6 (IL-6)Tumor necrosis factor-alpha (TNF-alpha)

Beyond the preview

Go deeper on Microbial and tissue components.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbial and tissue components.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call